Patents Examined by Deborah A Davis
  • Patent number: 10973859
    Abstract: Compositions include arginine and one or more unsaturated fatty acids. Methods for using such compositions can enhance cognitive function, reduce or prevent a decline of social interaction, reduce or prevent age-related behavioral changes, increase trainability, maintain optimal brain function, facilitate learning and memory, reduce memory loss, retard brain aging, prevent or treat strokes, and/or prevent or treat dementia in an animal. Preferably, the compositions are food compositions useful for enhancing cognitive function in humans and companion animals.
    Type: Grant
    Filed: October 3, 2018
    Date of Patent: April 13, 2021
    Assignee: SOCIÉTÉ DES PRODUITS NESTLÉ S. A.
    Inventor: Yuanlong Pan
  • Patent number: 10946057
    Abstract: The present invention is based on the surprising antiseptic nature of chlorhexidine when combined with essential oils. It has been found that chlorhexidine, combined with an essential oil, is surprisingly effective at penetrating the skin surface and providing an antiseptic effect within the skin. It has also been found that a combination of chlorhexidine and eucalyptus oil is surprisingly effective as an antimicrobial against Staphylococcus epidermidis.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: March 16, 2021
    Inventors: Tony Worthington, Tarja Karpanen
  • Patent number: 10939686
    Abstract: The present invention is directed to methods of controlling pathogenic fungi comprising applying sabadilla oil.
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: March 9, 2021
    Assignee: McLaughlin Gormley King Company
    Inventors: Robert A. Suranyi, Darrick David Unger
  • Patent number: 10918676
    Abstract: The present technology relates generally to formulations comprising egg white protein, methods of manufacturing egg protein formulations and uses for egg protein formulations. In particular, several embodiments are directed to egg protein formulations for oral administration in immunotherapy of subjects affected by egg allergies.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: February 16, 2021
    Assignee: Aimmune Therapeutics, Inc.
    Inventor: Howard V. Raff
  • Patent number: 10905748
    Abstract: A composition and method of maintaining fertility or treating retained placenta, reproductive tract infection, or reproductive tract inflammation in an animal involves administering ovotransferrin to the reproductive tract of the animal. The ovotransferrin administration protects against and treats reproductive tract infection, while protecting against and treating reproductive tract inflammation such as metritis, and thereby maintains fertility in the animal.
    Type: Grant
    Filed: April 16, 2018
    Date of Patent: February 2, 2021
    Assignee: VETS PLUS, INC.
    Inventors: Jamil Talukder, Abhijit Ray, Daniel J. DuBourdieu, Ajay Srivastava, Rajiv Lall
  • Patent number: 10905732
    Abstract: A drink includes an edible liquid or semisolid preparation and transfer factor. The drink may also include lactoferrin and one or more preservatives. An edible preparation includes a fruit component and transfer factor. The fruit component may include at least one oligoproanthocyanidin-containing fruit. The edible preparation may also include lactoferrin. One or more preservatives may also be included in the edible preparation. The drink or the edible preparation may be sterilized or pasteurized.
    Type: Grant
    Filed: May 1, 2018
    Date of Patent: February 2, 2021
    Assignee: 4Life Patents, LLC
    Inventors: Calvin W. McCausland, Brent Vaughan, David Lisonbee, William J. Hennen
  • Patent number: 10898537
    Abstract: The present application is directed to transdermal formulations comprising one or more capsaicinoinds, one or more 1,4-dialdehyde sesquiterpenes, a penetration enhancer comprising tetrahydropiperine and a transdermal formulation base. The formulations advantageously show improved color characteristics and cause less irritation compared to other known transdermal or topica formulations comprising capsaicinoinds.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: January 26, 2021
    Assignee: Delivra Inc.
    Inventors: Joseph Gabriele, Mikaela Teris, David Baranowski, Beth Buchanan
  • Patent number: 10898534
    Abstract: The invention relates to therapeutic compositions, solid oral dosage forms, and methods for treating, preventing, or alleviating lower urinary tract symptoms (LUTS), benign prostatic hyperplasia (BPH), erectile dysfunction (ED), urinary incontinence, bladder obstruction, overactive bladder (OAB), underactive bladder, interstitial cystitis, prostatitis, bladder and prostate inflammation, prostate fibrosis or pelvic pain. The therapeutic compositions can comprise cranberry powder enriched in cranberry seeds or cranberry seed meal.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: January 26, 2021
    Assignee: NATUREX Inc.
    Inventors: Emilie Annie Claudie Fromentin, Douglas Andrew Klaiber, Daniel David Souza
  • Patent number: 10869878
    Abstract: A use of isomaltulose in the preparation of a vaginal composition, wherein the amount of isomaltulose used is 0.05-20% (w/w). A vaginal composition contains 0.05-20% (w/w) of isomaltulose. The composition may be a health product, health care product, cleaning product, skin care product, deodorant, cosmetic, or disinfectant composition or a pharmaceutical composition. A non-therapeutic vaginal care method, a non-therapeutic vaginal cleaning method, a method for improving vaginal acidity, a method for promoting growth of Lactobacillus in the vagina, and a method for preventing and treating vaginal dysbacteriosis, especially bacterial vaginal diseases, these methods being implemented by administering the composition to women's vagina.
    Type: Grant
    Filed: September 12, 2016
    Date of Patent: December 22, 2020
    Assignee: SINGAPORE ZE&Z INTERNATIONAL PTE. LTD
    Inventors: Zhongming Zeng, Ruyun Zhou
  • Patent number: 10857192
    Abstract: This invention relates to the use Pulicaria incisa (Pi) infusion for granting cells and tissues with anti-oxidative effect. The invention further relates to the use Pulicaria incisa (Pi) infusion for treating neuroinflammatory conditions. The invention further relates to cultivated Pi in treating neuroinflammatory conditions and producing anti-oxidative effect.
    Type: Grant
    Filed: December 24, 2013
    Date of Patent: December 8, 2020
    Assignee: THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION
    Inventors: Anat Elmann, Rivka Ofir
  • Patent number: 10834926
    Abstract: The invention relates to the use of an extract of Sextonia rubra or the constituents thereof, rubrenolide and/or rubrynolide, as an insecticide agent against mosquitoes, especially as a larvicide agent.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: November 17, 2020
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE—CNRS, INSTITUT PASTEUR, UNIVERSITÉ DE GUYANE, UNIVERSITÉ DES ANTILLES, GUYANE DÉVELOPPEMENT INNOVATION
    Inventors: Michaël Falkowski, Alice De Souza Rodrigues, Véronique Éparvier, Isabelle Dusfour, Emeline Houël, Didier Stien
  • Patent number: 10813972
    Abstract: Methods, compositions and kits for the prevention and treatment of mitochondrial dysfunction, mitochondrial DNA damage and genomic DNA damage are provided. The methods use the administration of palm fruit juice and/or compositions containing phenolic compounds present in palm fruit juice. The methods, compositions, and kits can be used to reduce DNA damage in subjects being treated with nucleoside reverse transcriptase inhibitors, such as patients having HIV or AIDS.
    Type: Grant
    Filed: February 6, 2014
    Date of Patent: October 27, 2020
    Assignees: MALAYSIAN PALM OIL BOARD, BRANDEIS UNIVERSITY
    Inventors: Adam E. Osborne, Lawrence J. Wangh, Kenneth C. Hayes, Ravigadevi Sambanthamurthi
  • Patent number: 10786454
    Abstract: An aerosol liposome of a marine extract and a method of producing the same are introduced. The marine extract is extracted from cell membranes of marine processing streams, including phosphatidylserine (PS), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), and lysophosphatidylcholine (LysoPC), further including at least phosphatidylserine (PS). The aerosol liposome is of a particle diameter of less than 2,000 nm. The surface of the aerosol liposome carries phosphatidylserine (PS) molecules. The aerosol liposome of a marine extract, thus provided, is simple and stable and can be absorbed through the mouth, nose, upper respiratory tract, and epidermis and engulfed by macrophages therein to quickly alleviate or regulate systematic inflammatory responses and prevent inflammation-related diseases.
    Type: Grant
    Filed: October 20, 2016
    Date of Patent: September 29, 2020
    Assignee: FISHERIES RESEARCH INSTITUTE, COUNCIL OF AGRICULTURE
    Inventors: Yi-Feng Kao, Yi-Chen Chen, Chwen-Herng Wu
  • Patent number: 10772825
    Abstract: Compositions comprising extracts from marine organisms show beneficial effects on skin ailments. Fine lines, wrinkles, and sagging in skin are improved with the application of compositions with marine extracts. Production of collagen, elastin and hyaluronic acid are increased after application of the compositions.
    Type: Grant
    Filed: April 14, 2016
    Date of Patent: September 15, 2020
    Assignee: Marine Biology % Environmental Technologies, LLC
    Inventor: Eric Lewis
  • Patent number: 10772924
    Abstract: The present disclosure relates to health benefits of Chardonnay seed products.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: September 15, 2020
    Assignees: SONOMACEUTICALS, LLC, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE
    Inventors: Torey James Arvik, Rebecca Susan Lipson, Wallace H. Yokoyama
  • Patent number: 10743544
    Abstract: The present invention relates to a method for inactivating Cronobacter sakazakii, which belongs to the field of food safety technologies. The present invention provides a method to use tea polyphenols as an active ingredient to inactivate Cronobacter sakazakii. The invention can be used to control and eliminate the contamination of Cronobacter sakazakii in food or food processing, especially the contamination of Cronobacter sakazakii during PIF production. The present invention provides an effective method to clean and sterilize the environment and the equipment, especially to clean the inner wall of the equipment which is hard to clean due to biofilms formed inside.
    Type: Grant
    Filed: September 8, 2016
    Date of Patent: August 18, 2020
    Assignee: Northeast Agricultural University
    Inventors: Yujun Jiang, Chaoxin Man
  • Patent number: 10709754
    Abstract: The present invention relates to a composition for preventing, ameliorating, or treating hyperuricemia or metabolic disorders related with hyperuricemia comprising an extract of Alpinia oxyphylla as an effective ingredient. Because the extract of Alpinia oxyphylla of the present invention can reduce the uric acid amount in blood of an animal model and is derived from natural products, and the raw materials can be easily obtained, it can be widely used in industries that are related to hyperuricemia or metabolic disorders related with hyperuricemia. It can be effectively used for prevention, amelioration, or treatment of gout or gouty arthritis, in particular.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: July 14, 2020
    Assignee: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Dong Seon Kim, Ohn Soon Kim, Yun Mi Lee, Young-Sil Lee, Eun Jung Son
  • Patent number: 10695389
    Abstract: Disclosed are a method for preparing a ginseng polysaccharide for immune stimulation and a ginseng polysaccharide for immune stimulation prepared from the preparation method, the method comprising the steps of (1) adding ingredients; (2) performing an extraction; (3) performing a first filtration and cooling; (4) performing a second filtration; (5) performing a first concentration; (6) adding a concentrate to a fermentation alcohol; (7) separating into a supernatant and a precipitate; (8) collecting the precipitate; (9) dissolving in water; (10) performing a second concentration; (11) cold ageing; (12) performing a third concentration; (13) sterilizing; and (14) packaging into a product of the ginseng polysaccharide for immune stimulation in the form of a concentrate.
    Type: Grant
    Filed: April 27, 2015
    Date of Patent: June 30, 2020
    Assignee: HEALTH BIO MAD CO., LTD.
    Inventors: Seung Hui Lee, Gap Sun Park, Geum Hui Lee
  • Patent number: 10682385
    Abstract: A variety of medicinal compounds comprising Crocus sativus for the treatment of a plurality of medical ailments are described. A method of creating a Crocus sativus extract is also described. In addition, a variety of embodiments and methods of utilizing inhalation therapeutic delivery mechanisms including nebulizers and vaporizers for the vaporization of Crocus sativus comprising medicinal compounds and extracts are disclosed.
    Type: Grant
    Filed: January 12, 2015
    Date of Patent: June 16, 2020
    Inventors: Aftab Ahmad, Christine A. Frysz
  • Patent number: 10682382
    Abstract: The present invention relates to a composition for relieving one or more of the conditions of pain, stress and insomnia comprising Brassica compestris, Bees wax and Dryobalanops camphora. The present invention also provides a formulation comprising the composition of the present invention as well as method for preparation thereof, uses thereof and method of treatment of one or more of the conditions of pain, stress and insomnia.
    Type: Grant
    Filed: February 4, 2015
    Date of Patent: June 16, 2020
    Inventor: Ashvany Kumar Bansal